The Efficacy of 18F-FDG PET/CT and Superparamagnetic Nanoferric Oxide MRI in the Diagnosis of Lung Cancer and the Value of 18F-FDG PET/CT in the Prediction of Lymph Node Metastasis

Table 5

Clinical characteristics of patients.

Item	LM group ()	NLM group ()
Gender			0.578	0.447
Male	20 (32.79)	41 (67.21)
Female	10 (25.64)	29 (74.36)
Age (year)			0.002	0.965
<60	14 (29.79)	33 (70.21)
≥60	16 (30.19)	37 (69.81)
Number of lesions			0.052	0.819
<10	19 (29.23)	46 (70.77)
≥10	11 (31.43)	24 (68.57)
Maximum diameter of lesion (cm)			7.113	0.008
<5.0	8 (17.02)	39 (82.98)
≥5.0	22 (41.51)	31 (58.49)
Types of lung cancer			0.846	0.358
Central type	21 (27.63)	55 (72.37)
Peripheral	9 (37.50)	15 (62.50)
TNM classification			0.157	0.692
I, II	12 (27.91)	31 (72.09)
III	18 (31.58)	39 (68.42)